The usability and feasibility of a self‐compassion chatbot ( COMPASS ) for youth living with type 1 diabetes
Authors' conclusion
The COMPASS chatbot was demonstrated to be safe, feasible and acceptable to adolescents living with T1D. Future research aims to conduct a hybrid type 1 effectiveness-implementation trial that will leverage updates in artificial intelligence to increase the flexibility and tailoring of responding.
Study context
- Population
- Adolescents aged 12–16 years living with T1D32 completed
- Participants
- 40 adolescents
- Outcome
- Safety, usability and feasibility of COMPASS
Methodological detailssingle-group, mixed methods
- Single-group
- Mixed methods
Main finding
As reported in the abstract
Feasibility · 12 weeks
Completed the study
32
80%
Mean share of started modules completed
95%
Further findings
Psychosocial measures · 6- and 12-week follow-ups
- Promising reductions in diabetes distress and improvements in resilience, self-efficacy, self-compassion and emotional well-being
Original publication
The usability and feasibility of a self‐compassion chatbot ( COMPASS ) for youth living with type 1 diabetes. Diabet Med. Published 27 July 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →